HONORHEALTH SCOTTSDALE OSBORN MED CT
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $4.9M
- Transactions
- 888
- Companies
- 40
- Average per transaction
- $5,541
Who reported the payments
| Amgen | $1,015,099 |
| CSL Behring | $691,135 |
| Corcept Therapeutics | $548,408 |
| Medtronic | $430,711 |
| Regeneron | $297,920 |
| Bristol Myers Squibb | $246,955 |
| Genentech, Inc. | $202,235 |
| Daiichi Sankyo Inc. | $185,482 |
| AstraZeneca | $153,892 |
| Boston Scientific | $150,510 |
| Gilead | $108,929 |
| Sanofi US Services Inc. | $106,949 |
| Acutus Medical, Inc. | $100,750 |
| Galvanize Therapeutics, Inc | $96,641 |
| Incyte Corporation | $74,011 |
| AbbVie | $68,819 |
| GT Medical Technologies, Inc | $55,946 |
| Pharmacyclics LLC, An Abbvie Company | $55,766 |
| Livanova USA, Inc. | $47,560 |
| Shockwave Medical, Inc | $32,910 |
| EMD Serono, Inc. | $32,348 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | $31,872 |
| MIVI Neuroscience, Inc. | $31,645 |
| Olympus America Inc. | $31,312 |
| Contego Medical, Inc | $20,124 |
| Stryker | $16,275 |
| Sanofi | $12,962 |
| Silk Road Medical, Inc. | $12,807 |
| UCB SA | $11,718 |
| Astrazeneca UK Limited | $8,290 |
| E.r. Squibb & Sons, L.L.C. | $7,580 |
| Angiodynamics, Inc. | $7,167 |
| Merck | $6,048 |
| Adaptimmune LLC | $5,166 |
| Seagen Inc. | $4,250 |
| Zimmer Biomet | $2,928 |
| Takeda Pharmaceuticals U.S.A., Inc. | $2,894 |
| Cardiva Medical, Inc. | $2,500 |
| Atricure, Inc. | $1,000 |
| Johnson & Johnson | $269 |